Pyridine → Isopropyl 5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carboxylate
反応式
[NH:1]1[CH2:7][CH2:6][CH2:5][C:4](=[O:8])[C:3]2[CH:9]=[CH:10][CH:11]=[CH:12][C:2]1=2.N1C=CC=CC=1.[CH:19]([O:22][C:23](Cl)=[O:24])([CH3:21])[CH3:20]>ClCCl>[CH:19]([O:22][C:23]([N:1]1[CH2:7][CH2:6][CH2:5][C:4](=[O:8])[C:3]2[CH:9]=[CH:10][CH:11]=[CH:12][C:2]1=2)=[O:24])([CH3:21])[CH3:20]参加物
実験手順
To a cooled (0° C.) solution of 1,2,3,4-Tetrahydro-benzo[b]azepin-5-one (1.5 g, 9.3 mmol) and pyridine (2.26 ml, 27.9 mmol) in dichloromethane (30 ml) was added 1M isopropylchloroformate (solution in toluene) dropwise over 10 minutes. After addition was completed, the mixture was removed from the cold bath and stirred for 18 hours at room temperature. The mixture was cooled to 0° C., then treated with aqueous 1N NaOH and stirred for 30 minutes. After layer separation, the aqueous layer was extracted with dichloromethane. The combined organic phases were washed with 1N HCl, saturated aqueous NaHCO3, brine, then dried (Na2SO4) and concentrated to an oil. Purification by silica gel chromatography (eluent, 3:1 n-hexanes:ethyl acetate) provided 5-Oxo-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester (1.91 g).
後処理
- additionAfter addition
- customthe mixture was removed from the cold bath
- temperatureThe mixture was cooled to 0° C.
- additiontreated with aqueous 1N NaOH
- stirringstirred for 30 minutes
- customAfter layer separation
- extractionthe aqueous layer was extracted with dichloromethane
- washThe combined organic phases were washed with 1N HCl, saturated aqueous NaHCO3, brine
- dry with materialdried (Na2SO4)
- concentrationconcentrated to an oil
- customPurification by silica gel chromatography (eluent, 3:1 n-hexanes:ethyl acetate)
出典と根拠
- ORDレコード
- ord-92c4e69867ef4cbf8ec6578f77668030
- 出典データセット
- uspto-grants-2010_07
- 特許番号
- US07749992B2
反応ノート
読み込み中…